Zacks Investment Research
30 Jun 2026, 19:46 UTC · 1h ago
Is COO Stock Attractive as MyDay Gains Meet Asia-Pacific Pressure
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
30 Jun 2026, 19:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
The Cooper Companies (COO) experienced a 6% organic sales decline in the Asia-Pacific region during fiscal Q2 2026 due to soft conditions in Japan, China, and Korea. — Regional revenue contraction in major Asian markets creates a significant headwind for growth and adds uncertainty to the stock's near-term valuation.
-0.50The MyDay brand delivered double-digit growth in fiscal Q2 2026, driven by daily silicone hydrogel adoption. — Strong performance in premium product lines indicates successful pricing power and a shift toward higher-margin revenue streams.
+0.40Management reduced CooperVision's full-year organic growth outlook to a range of 3.5% to 4.5%. — A trimmed growth outlook typically signals a cooling of momentum and may lead to downward revisions in analyst price targets.
-0.30Continue reading
6 related stories
Top 1 mover · tap to explore
COO shares have gained 18.6% over the past month, significantly outperforming the industry average of 8.5%. — Strong recent price momentum suggests bullish investor sentiment and relative strength compared to peers like Alcon and Bausch + Lomb.
+0.20Which stocks this story touches
The company shows long-term strength in premium lenses and fertility, though short-term headwinds exist in Asia-Pacific.
Mentioned only as a peer for comparison.
Mentioned only as a peer for comparison.
[mutual] Alcon Inc. is described as a relevant peer that competes across eye-care categories including vision care and surgical products.
[mutual] Bausch + Lomb is cited as a comparison point for investors watching contact lenses, lens care, and eye-surgery exposure.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
29m ago
